☰

Michael Egan - Publications

Affiliations: 
2004 Washington State University, Pullman, WA, United States 
Tree Info Similar researchers PubMed Report error

0/145 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2023 Mulryan K, O'Connor J, Egan M, Redmond K. Tracheobronchomalacia: an unusual cause of debilitating dyspnoea and its surgical management. Bmj Case Reports. 16. PMID 37977838 DOI: 10.1136/bcr-2022-254229  0.01
2023 Tucker MA, Schipper AM, Adams TSF, Attias N, Avgar T, Babic NL, Barker KJ, Bastille-Rousseau G, Behr DM, Belant JL, Beyer DE, Blaum N, Blount JD, Bockmühl D, Pires Boulhosa RL, ... ... Egan M, et al. Behavioral responses of terrestrial mammals to COVID-19 lockdowns. Science (New York, N.Y.). 380: 1059-1064. PMID 37289888 DOI: 10.1126/science.abo6499  0.01
2023 Wilson GJ, Rodriguez B, Li SS, Allen M, Frank I, Rudnicki E, Trahey M, Kalams S, Hannaman D, Clarke DK, Xu R, Egan M, Eldridge J, Pensiero M, Latham T, et al. Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial. Vaccine. PMID 36935288 DOI: 10.1016/j.vaccine.2023.03.015  0.01
2023 Voss T, Kost J, Mercer SP, Furtek C, Randolph C, Lines C, Egan MF, Cummings JL. Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions. Journal of Alzheimer's Disease : Jad. PMID 36744336 DOI: 10.3233/JAD-220836  0.01
2022 Safavi D, Subramaniam VS, Obeidi N, Egan M, Abu Saadeh F. Post-operative ureteral injury after cytoreductive surgery for ovarian cancer managed by primary repair through minimally invasive approach. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 36446411 DOI: 10.1136/ijgc-2022-003963  0.01
2022 Cross RW, Longini IM, Becker S, Bok K, Boucher D, Carroll MW, Díaz JV, Dowling WE, Draghia-Akli R, Duworko JT, Dye JM, Egan MA, Fast P, Finan A, Finch C, et al. An introduction to the Marburg virus vaccine consortium, MARVAC. Plos Pathogens. 18: e1010805. PMID 36227853 DOI: 10.1371/journal.ppat.1010805  0.01
2022 Sur C, Adamczuk K, Scott D, Kost J, Sampat M, Buckley C, Farrar G, Newton B, Suhy J, Bennacef I, Egan MF. Evaluation of F-flutemetamol amyloid PET image analysis parameters on the effect of verubecestat on brain amlyoid load in Alzheimer's disease. Molecular Imaging and Biology. PMID 35794343 DOI: 10.1007/s11307-022-01735-z  0.01
2022 Woolsey C, Cross RW, Agans KN, Borisevich V, Deer DJ, Geisbert JB, Gerardi C, Latham TE, Fenton KA, Egan MA, Eldridge JH, Geisbert TW, Matassov D. A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge. Plos Neglected Tropical Diseases. 16: e0010433. PMID 35622847 DOI: 10.1371/journal.pntd.0010433  0.01
2022 Dockendorf MF, Jaworowicz D, Humphrey R, Anderson M, Breidinger S, Ma L, Taylor T, Dupre N, Jones C, Furtek C, Kantesaria B, Bateman KP, Woolf E, Egan MF, Stone JA. A Model-Based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verubecestat Trials. The Aaps Journal. 24: 53. PMID 35384522 DOI: 10.1208/s12248-022-00682-5  0.01
2022 Tricou V, Gottardo R, Egan MA, Clement F, Leroux-Roels G, Sáez-Llorens X, Borkowski A, Wallace D, Dean HJ. Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting. Vaccine. 40: 1143-1151. PMID 35078666 DOI: 10.1016/j.vaccine.2022.01.016  0.01
2021 Eldridge JH, Egan MA, Matassov D, Hamm S, Hermida L, Chen T, Tremblay M, Sciotto-Brown S, Xu R, Dimitrov A, Smith ER, Gurwith M, Chen RT. A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses. Vaccine. PMID 34373117 DOI: 10.1016/j.vaccine.2021.07.030  0.01
2021 Tsuji I, Dominguez D, Egan MA, Dean HJ. Development of a novel assay to assess the avidity of dengue virus-specific antibodies elicited in response to a tetravalent dengue vaccine. The Journal of Infectious Diseases. PMID 33534885 DOI: 10.1093/infdis/jiab064  0.01
2021 Srinivasan K, Egan M. From airway 'grading' to 'coding'. European Journal of Anaesthesiology. 38: 205-206. PMID 33394803 DOI: 10.1097/EJA.0000000000001314  0.01
2020 Sur C, Kost J, Scott D, Adamczuk K, Fox NC, Cummings JL, Tariot PN, Aisen PS, Vellas B, Voss T, Mahoney E, Mukai Y, Kennedy ME, Lines C, Michelson D, ... Egan MF, et al. BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain. Brain : a Journal of Neurology. PMID 33253354 DOI: 10.1093/brain/awaa332  0.01
2020 Sergott RC, Raji A, Kost J, Sur C, Jackson S, Locco A, Patel A, Furtek C, Mattson B, Egan MF. Retinal Optical Coherence Tomography Metrics are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy. Journal of Alzheimer's Disease : Jad. PMID 33252075 DOI: 10.3233/JAD-200735  0.01
2020 Wessels AM, Lines C, Stern RA, Kost J, Voss T, Mozley LH, Furtek C, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, Dupre N, Randolph C, Michelson D, ... ... Egan MF, et al. Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33049114 DOI: 10.1002/alz.12164  0.01
2020 Clarke DK, Xu R, Matassov D, Latham TE, Ota-Setlik A, Gerardi CS, Luckay A, Witko SE, Hermida L, Higgins T, Tremblay M, Sciotto-Brown S, Chen T, Egan MA, Rusnak JM, et al. Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial. The Lancet. Infectious Diseases. PMID 31952923 DOI: 10.1016/S1473-3099(19)30614-0  0.01
2019 Egan MF, Mukai Y, Voss T, Kost J, Stone J, Furtek C, Mahoney E, Cummings JL, Tariot PN, Aisen PS, Vellas B, Lines C, Michelson D. Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's disease. Alzheimer's Research & Therapy. 11: 68. PMID 31387606 DOI: 10.1186/S13195-019-0520-1  0.01
2019 Kennedy ME, Egan MF. Verubecestat for Prodromal Alzheimer's Disease. Reply. The New England Journal of Medicine. 381: 389. PMID 31340106 DOI: 10.1056/NEJMc1906679  0.01
2019 O'Callaghan TF, Mannion D, Apopei D, McCarthy NA, Hogan SA, Kilcawley KN, Egan M. Influence of Supplemental Feed Choice for Pasture-Based Cows on the Fatty Acid and Volatile Profile of Milk. Foods (Basel, Switzerland). 8. PMID 31013643 DOI: 10.3390/foods8040137  0.01
2019 Egan MF, Kost J, Voss T, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, van Dyck CH, Boada M, Zhang Y, Li W, Furtek C, Mahoney E, Harper Mozley L, et al. Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease. The New England Journal of Medicine. 380: 1408-1420. PMID 30970186 DOI: 10.1056/Nejmoa1812840  0.01
2019 Sharma M, Glasner DR, Watkins H, Puerta-Guardo H, Kassa Y, Egan MA, Dean H, Harris E. Magnitude and Functionality of the NS1-Specific Antibody Response Elicited by a Live-Attenuated Tetravalent Dengue Vaccine Candidate. The Journal of Infectious Diseases. PMID 30783676 DOI: 10.1093/Infdis/Jiz081  0.01
2018 Elizaga ML, Li SS, Kochar NK, Wilson GJ, Allen MA, Tieu HVN, Frank I, Sobieszczyk ME, Cohen KW, Sanchez B, Latham TE, Clarke DK, Egan MA, Eldridge JH, Hannaman D, et al. Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial. Plos One. 13: e0202753. PMID 30235286 DOI: 10.1371/journal.pone.0202753  0.01
2018 Voss T, Li J, Cummings J, Farlow M, Assaid C, Froman S, Leibensperger H, Snow-Adami L, McMahon KB, Egan M, Michelson D. Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 173-181. PMID 29955661 DOI: 10.1016/J.Trci.2018.03.004  0.01
2018 Ursini G, Punzi G, Chen Q, Marenco S, Robinson JF, Porcelli A, Hamilton EG, Mitjans M, Maddalena G, Begemann M, Seidel J, Yanamori H, Jaffe AE, Berman KF, Egan MF, et al. Convergence of placenta biology and genetic risk for schizophrenia. Nature Medicine. PMID 29808008 DOI: 10.1038/S41591-018-0021-Y  0.01
2018 Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C, Mahoney E, Harper Mozley L, Vandenberghe R, Mo Y, Michelson D. Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease. The New England Journal of Medicine. 378: 1691-1703. PMID 29719179 DOI: 10.1056/Nejmoa1706441  0.01
2017 Sneller MC, Justement JS, Gittens KR, Petrone ME, Clarridge KE, Proschan MA, Kwan R, Shi V, Blazkova J, Refsland EW, Morris DE, Cohen KW, McElrath MJ, Xu R, Egan MA, et al. A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection. Science Translational Medicine. 9. PMID 29212716 DOI: 10.1126/scitranslmed.aan8848  0.01
2017 Matassov D, Mire CE, Latham T, Geisbert JB, Xu R, Ota-Setlik A, Agans KN, Kobs DJ, Wendling MQS, Burnaugh A, Rudge TL, Sabourin CL, Egan MA, Clarke DK, Geisbert TW, et al. Single Dose Trivalent Vesiculovax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge. Journal of Virology. PMID 29142131 DOI: 10.1128/Jvi.01190-17  0.01
2017 Li SS, Kochar NK, Elizaga M, Hay CM, Wilson GJ, Cohen KW, De Rosa SC, Xu R, Ota-Setlik A, Morris D, Finak G, Allen M, Tieu HV, Frank I, Sobieszczyk ME, ... ... Egan MA, et al. DNA priming increases frequency of T-cell responses to a VSV HIV vaccine with specific enhancement of CD8(+) T-cell responses by IL-12 pDNA. Clinical and Vaccine Immunology : Cvi. PMID 28931520 DOI: 10.1128/Cvi.00263-17  0.01
2017 Mo Y, Stromswold J, Wilson K, Holder D, Sur C, Laterza O, Savage MJ, Struyk A, Scheltens P, Teunissen CE, Burke J, Macaulay SL, Bråthen G, Sando SB, White LR, ... ... Egan MF, et al. A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging. Alzheimer's & Dementia (Amsterdam, Netherlands). 6: 201-209. PMID 28349119 DOI: 10.1016/J.Dadm.2017.02.004  0.01
2016 Kennedy ME, Stamford AW, Chen X, Cox K, Cumming JN, Dockendorf MF, Egan M, Ereshefsky L, Hodgson RA, Hyde LA, Jhee S, Kleijn HJ, Kuvelkar R, Li W, Mattson BA, et al. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients. Science Translational Medicine. 8: 363ra150. PMID 27807285 DOI: 10.1126/scitranslmed.aad9704  0.01
2016 Jacobson JM, Zheng L, Wilson CC, Tebas P, Matining RM, Egan MA, Eldridge J, Landay AL, Clifford DB, Luetkemeyer AF, Tiu J, Martinez AL, Janik J, Spitz TA, Hural J, et al. The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection. Journal of Acquired Immune Deficiency Syndromes (1999). 71: 163-71. PMID 26761518 DOI: 10.1097/QAI.0000000000000830  0.01
2016 Fouts T, Prado I, Bobb K, Schwartz J, Bagley K, Xu R, Otya-Setlik A, Egan M, Eldridge J, Montefiori D, LaBranche C, Pal R, Pavlakis G, Felber B, Franchini G, et al. G-111 DNA prime/subunit boost using SIVE660 based rhFLSC yields 75% efficacy against cross clade SIVmac251 intrarectal challenge: Journal of Acquired Immune Deficiency Syndromes. 71: 69. DOI: 10.1097/01.Qai.0000479705.71198.09  0.01
2015 Schotola H, Kirsch KC, Höcker J, Egan M, Büttner B, Wiese C, Mansur A, Hinz JM, Bergmann I. Ketamine in outpatient arthroscopic shoulder surgery: Effects on postoperative pain, hemodynamic stability and process times. Open Medicine (Warsaw, Poland). 10: 297-305. PMID 28352709 DOI: 10.1515/med-2015-0043  0.01
2015 Mpendo J, Mutua G, Nyombayire J, Ingabire R, Nanvubya A, Anzala O, Karita E, Hayes P, Kopycinski J, Dally L, Hannaman D, Egan MA, Eldridge JH, Syvertsen K, Lehrman J, et al. A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults. Plos One. 10: e0134287. PMID 26252526 DOI: 10.1371/journal.pone.0134287  0.01
2015 Fuchs JD, Frank I, Elizaga ML, Allen M, Frahm N, Kochar N, Li S, Edupuganti S, Kalams SA, Tomaras GD, Sheets R, Pensiero M, Tremblay MA, Higgins TJ, Latham T, ... Egan MA, et al. First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090). Open Forum Infectious Diseases. 2: ofv082. PMID 26199949 DOI: 10.1093/Ofid/Ofv082  0.01
2015 Matassov D, Marzi A, Latham T, Xu R, Ota-Setlik A, Feldmann F, Geisbert JB, Mire CE, Hamm S, Nowak B, Egan MA, Geisbert TW, Eldridge JH, Feldmann H, Clarke DK. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus. The Journal of Infectious Diseases. 212: S443-51. PMID 26109675 DOI: 10.1093/Infdis/Jiv316  0.01
2015 Bagley K, Xu R, Ota-Setlik A, Egan M, Schwartz J, Fouts T. The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses. Human Vaccines & Immunotherapeutics. 11: 2228-40. PMID 26042527 DOI: 10.1080/21645515.2015.1026498  0.01
2015 Mire CE, Matassov D, Geisbert JB, Latham TE, Agans KN, Xu R, Ota-Setlik A, Egan MA, Fenton KA, Clarke DK, Eldridge JH, Geisbert TW. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus. Nature. 520: 688-91. PMID 25853476 DOI: 10.1038/Nature14428  0.01
2015 Fouts TR, Bagley K, Prado IJ, Bobb KL, Schwartz JA, Xu R, Zagursky RJ, Egan MA, Eldridge JH, LaBranche CC, Montefiori DC, Le Buanec H, Zagury D, Pal R, Pavlakis GN, et al. Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection. Proceedings of the National Academy of Sciences of the United States of America. 112: E992-9. PMID 25681373 DOI: 10.1097/01.Qai.0000479717.30834.7D  0.01
2015 Daurat A, Choquet O, Bringuier S, Charbit J, Egan M, Capdevila X. Diagnosis of Postoperative Urinary Retention Using a Simplified Ultrasound Bladder Measurement. Anesthesia and Analgesia. 120: 1033-8. PMID 25642660 DOI: 10.1213/ANE.0000000000000595  0.01
2014 Orliaguet GA, Gall O, Egan M, Salvi N, Bernard R, Treluyer JM, Carli PA. Response to Voepel-Lewis and Malviya's comment 'pain score guided morphine titration is risky and inappropriate'. Paediatric Anaesthesia. 24: 641-2. PMID 24809840 DOI: 10.1111/pan.12407  0.01
2014 Clarke DK, Nasar F, Chong S, Johnson JE, Coleman JW, Lee M, Witko SE, Kotash CS, Abdullah R, Megati S, Luckay A, Nowak B, Lackner A, Price RE, Little P, ... ... Egan MA, et al. Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates. Journal of Virology. 88: 6690-701. PMID 24696472 DOI: 10.1128/Jvi.03441-13  0.01
2014 Weickert TW, Terrazas A, Bigelow LB, Apud JA, Egan MF, Weinberger DR. Perceptual Category Judgment Deficits are Related to Prefrontal Decision Making Abnormalities in Schizophrenia. Frontiers in Psychiatry. 4: 184. PMID 24432006 DOI: 10.3389/fpsyt.2013.00184  0.01
2014 Bernard R, Salvi N, Gall O, Egan M, Treluyer JM, Carli PA, Orliaguet GA. MORPHIT: an observational study on morphine titration in the postanesthetic care unit in children. Paediatric Anaesthesia. 24: 303-8. PMID 24205822 DOI: 10.1111/pan.12286  0.01
2013 Weickert TW, Mattay VS, Das S, Bigelow LB, Apud JA, Egan MF, Weinberger DR, Goldberg TE. Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson's disease. Schizophrenia Research. 149: 162-6. PMID 23830543 DOI: 10.1016/j.schres.2013.06.028  0.01
2013 Egan MF, Zhao X, Smith A, Troyer MD, Uebele VN, Pidkorytov V, Cox K, Murphy M, Snavely D, Lines C, Michelson D. Randomized controlled study of the T-type calcium channel antagonist MK-8998 for the treatment of acute psychosis in patients with schizophrenia. Human Psychopharmacology. 28: 124-33. PMID 23532746 DOI: 10.1002/hup.2289  0.01
2013 Allyn J, Guglielminotti J, Omnes S, Guezouli L, Egan M, Jondeau G, Longrois D, Montravers P. Marfan's syndrome during pregnancy: anesthetic management of delivery in 16 consecutive patients. Anesthesia and Analgesia. 116: 392-8. PMID 23302979 DOI: 10.1213/ANE.0b013e3182768f78  0.01
2013 Hostetler ED, Sanabria-Bohórquez S, Eng W, Joshi AD, Patel S, Gibson RE, O'Malley S, Krause SM, Ryan C, Riffel K, Bi S, Okamoto O, Kawamoto H, Ozaki S, Ohta H, ... ... Egan M, et al. Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human. Neuroimage. 68: 1-10. PMID 23238431 DOI: 10.1016/J.Neuroimage.2012.11.053  0.01
2012 Egan M. Barry Commoner's place in history. Science (New York, N.Y.). 338: 1028. PMID 23180843 DOI: 10.1126/science.338.6110.1028-a  0.01
2012 Sachdeva RC, Aranha SL, Egan ME, Gross HT, Sachdeva NS, Currier GF, Kadioglu O. Treatment time: SureSmile vs conventional. Orthodontics : the Art and Practice of Dentofacial Enhancement. 13: 72-85. PMID 22567618  0.01
2012 Egan M, Yaari R, Liu L, Ryan M, Peng Y, Lines C, Michelson D. Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD. Current Alzheimer Research. 9: 481-90. PMID 22272611  0.01
2012 Kopald BE, Mirra KM, Egan MF, Weinberger DR, Goldberg TE. Magnitude of impact of executive functioning and IQ on episodic memory in Schizophrenia. Biological Psychiatry. 71: 545-51. PMID 22265665 DOI: 10.1016/j.biopsych.2011.11.021  0.01
2010 Bondar A, Egan M, Jochum D, Amarenco G, Bouaziz H. Case report: pudendal nerve injury after a sciatic nerve block by the posterior approach. Anesthesia and Analgesia. 111: 573-5. PMID 20584876 DOI: 10.1213/ANE.0b013e3181e36994  0.01
2010 Weickert TW, Goldberg TE, Egan MF, Apud JA, Meeter M, Myers CE, Gluck MA, Weinberger DR. Relative risk of probabilistic category learning deficits in patients with schizophrenia and their siblings. Biological Psychiatry. 67: 948-55. PMID 20172502 DOI: 10.1016/J.Biopsych.2009.12.027  0.01
2009 Shields N, White M, Egan M. [Battlefield Blues: Ambivalence about treatment among military Veterans with depression]. Canadian Family Physician MéDecin De Famille Canadien. 55: 799-802. PMID 19675264  0.01
2009 Xu R, Nasar F, Megati S, Luckay A, Lee M, Udem SA, Eldridge JH, Egan MA, Emini E, Clarke DK. Prime-boost vaccination with recombinant mumps virus and recombinant vesicular stomatitis virus vectors elicits an enhanced human immunodeficiency virus type 1 Gag-specific cellular immune response in rhesus macaques. Journal of Virology. 83: 9813-23. PMID 19625392 DOI: 10.1128/JVI.00550-09  0.01
2009 Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, Yang F, Mattay V, Lipska BK, Hyde TM, Song J, Rujescu D, Giegling I, Mayilyan K, Proust MJ, Soghoyan A, Caforio G, ... ... Egan MF, et al. A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nature Medicine. 15: 509-18. PMID 19412172 DOI: 10.1038/Nm.1962  0.01
2009 Weickert TW, Goldberg TE, Callicott JH, Chen Q, Apud JA, Das S, Zoltick BJ, Egan MF, Meeter M, Myers C, Gluck MA, Weinberger DR, Mattay VS. Neural correlates of probabilistic category learning in patients with schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1244-54. PMID 19176832 DOI: 10.1523/Jneurosci.4341-08.2009  0.01
2009 Spearman P, Kalams S, Elizaga M, Metch B, Chiu YL, Allen M, Weinhold KJ, Ferrari G, Parker SD, McElrath MJ, Frey SE, Fuchs JD, Keefer MC, Lubeck MD, Egan M, et al. Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial. Vaccine. 27: 243-9. PMID 18996425 DOI: 10.1016/J.Vaccine.2008.10.051  0.01
2008 Kempf L, Nicodemus KK, Kolachana B, Vakkalanka R, Verchinski BA, Egan MF, Straub RE, Mattay VA, Callicott JH, Weinberger DR, Meyer-Lindenberg A. Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function. Plos Genetics. 4: e1000252. PMID 18989458 DOI: 10.1371/journal.pgen.1000252  0.01
2008 Hyde TM, Deep-Soboslay A, Iglesias B, Callicott JH, Gold JM, Meyer-Lindenberg A, Honea RA, Bigelow LB, Egan MF, Emsellem EM, Weinberger DR. Enuresis as a premorbid developmental marker of schizophrenia. Brain : a Journal of Neurology. 131: 2489-98. PMID 18669483 DOI: 10.1093/Brain/Awn167  0.01
2008 Xu R, Megati S, Roopchand V, Luckay A, Masood A, Garcia-Hand D, Rosati M, Weiner DB, Felber BK, Pavlakis GN, Sidhu MK, Eldridge JH, Egan MA. Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines. Vaccine. 26: 4819-29. PMID 18657584 DOI: 10.1016/J.Vaccine.2008.06.103  0.01
2008 Skelley SL, Goldberg TE, Egan MF, Weinberger DR, Gold JM. Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia. Schizophrenia Research. 105: 78-85. PMID 18617370 DOI: 10.1016/J.Schres.2008.05.027  0.01
2008 Ceaser AE, Goldberg TE, Egan MF, McMahon RP, Weinberger DR, Gold JM. Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype? Biological Psychiatry. 64: 782-8. PMID 18597738 DOI: 10.1016/J.Biopsych.2008.05.009  0.01
2008 Megati S, Garcia-Hand D, Cappello S, Roopchand V, Masood A, Xu R, Luckay A, Chong SY, Rosati M, Sackitey S, Weiner DB, Felber BK, Pavlakis GN, Israel ZR, Smith LR, ... ... Egan MA, et al. Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses. Vaccine. 26: 5083-94. PMID 18485543 DOI: 10.1016/J.Vaccine.2008.03.092  0.01
2008 Matsumoto M, Straub RE, Marenco S, Nicodemus KK, Matsumoto S, Fujikawa A, Miyoshi S, Shobo M, Takahashi S, Yarimizu J, Yuri M, Hiramoto M, Morita S, Yokota H, Sasayama T, ... ... Egan MF, et al. The evolutionarily conserved G protein-coupled receptor SREB2/GPR85 influences brain size, behavior, and vulnerability to schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 105: 6133-8. PMID 18413613 DOI: 10.1073/pnas.0710717105  0.01
2008 Meyer-Lindenberg A, Nicodemus KK, Egan MF, Callicott JH, Mattay V, Weinberger DR. False positives in imaging genetics. Neuroimage. 40: 655-61. PMID 18201908 DOI: 10.1016/j.neuroimage.2007.11.058  0.01
2008 Goldberg TE, Iudicello J, Russo C, Elvevåg B, Straub R, Egan MF, Weinberger DR. BDNF Val66Met polymorphism significantly affects d' in verbal recognition memory at short and long delays. Biological Psychology. 77: 20-4. PMID 17988784 DOI: 10.1016/j.biopsycho.2007.08.009  0.01
2008 Diaz-Asper CM, Goldberg TE, Kolachana BS, Straub RE, Egan MF, Weinberger DR. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biological Psychiatry. 63: 72-9. PMID 17707347 DOI: 10.1016/j.biopsych.2007.03.031  0.01
2008 Honea RA, Meyer-Lindenberg A, Hobbs KB, Pezawas L, Mattay VS, Egan MF, Verchinski B, Passingham RE, Weinberger DR, Callicott JH. Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biological Psychiatry. 63: 465-74. PMID 17689500 DOI: 10.1016/j.biopsych.2007.05.027  0.01
2007 Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques. Vaccine. 25: 7132-44. PMID 17850933 DOI: 10.1016/j.vaccine.2007.07.065  0.01
2007 Hyde TM, Goldberg TE, Egan MF, Lener MC, Weinberger DR. Frontal release signs and cognition in people with schizophrenia, their siblings and healthy controls. The British Journal of Psychiatry : the Journal of Mental Science. 191: 120-5. PMID 17666495 DOI: 10.1192/bjp.bp.106.026773  0.01
2007 Tan HY, Chen Q, Sust S, Buckholtz JW, Meyers JD, Egan MF, Mattay VS, Meyer-Lindenberg A, Weinberger DR, Callicott JH. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proceedings of the National Academy of Sciences of the United States of America. 104: 12536-41. PMID 17636131 DOI: 10.1073/pnas.0610125104  0.01
2007 Genderson MR, Dickinson D, Diaz-Asper CM, Egan MF, Weinberger DR, Goldberg TE. Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controls. Schizophrenia Research. 94: 231-9. PMID 17570645 DOI: 10.1016/J.Schres.2006.12.031  0.01
2007 Egan MA. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever? Expert Review of Vaccines. 6: 289-91. PMID 17542741 DOI: 10.1586/14760584.6.3.289  0.01
2007 Chong SY, Egan MA, Kutzler MA, Megati S, Masood A, Roopchard V, Garcia-Hand D, Montefiori DC, Quiroz J, Rosati M, Schadeck EB, Boyer JD, Pavlakis GN, Weiner DB, Sidhu M, et al. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. Vaccine. 25: 4967-82. PMID 17335943 DOI: 10.1016/J.Vaccine.2006.11.070  0.01
2007 Luckay A, Sidhu MK, Kjeken R, Megati S, Chong SY, Roopchand V, Garcia-Hand D, Abdullah R, Braun R, Montefiori DC, Rosati M, Felber BK, Pavlakis GN, Mathiesen I, Israel ZR, ... ... Egan MA, et al. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. Journal of Virology. 81: 5257-69. PMID 17329330 DOI: 10.1128/JVI.00055-07  0.01
2007 Buckholtz JW, Meyer-Lindenberg A, Honea RA, Straub RE, Pezawas L, Egan MF, Vakkalanka R, Kolachana B, Verchinski BA, Sust S, Mattay VS, Weinberger DR, Callicott JH. Allelic variation in RGS4 impacts functional and structural connectivity in the human brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 1584-93. PMID 17301167 DOI: 10.1523/JNEUROSCI.5112-06.2007  0.01
2007 Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, Egan MF, Huffaker SS, Mattay VS, Kolachana B, Kleinman JE, Weinberger DR. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. The Journal of Clinical Investigation. 117: 672-82. PMID 17290303 DOI: 10.1172/JCI30413  0.01
2007 Paluska TR, Sise MJ, Sack DI, Sise CB, Egan MC, Biondi M. Incidental CT findings in trauma patients: incidence and implications for care of the injured. The Journal of Trauma. 62: 157-61. PMID 17215748 DOI: 10.1097/01.ta.0000249129.63550.cc  0.01
2007 Apud JA, Mattay V, Chen J, Kolachana BS, Callicott JH, Rasetti R, Alce G, Iudicello JE, Akbar N, Egan MF, Goldberg TE, Weinberger DR. Tolcapone improves cognition and cortical information processing in normal human subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1011-20. PMID 17063156 DOI: 10.1038/sj.npp.1301227  0.01
2007 Nicodemus KK, Kolachana BS, Vakkalanka R, Straub RE, Giegling I, Egan MF, Rujescu D, Weinberger DR. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Human Genetics. 120: 889-906. PMID 17006672 DOI: 10.1007/s00439-006-0257-3  0.01
2006 Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Archives of General Psychiatry. 63: 1396-406. PMID 17146014 DOI: 10.1001/Archpsyc.63.12.1396  0.01
2006 Tan HY, Sust S, Buckholtz JW, Mattay VS, Meyer-Lindenberg A, Egan MF, Weinberger DR, Callicott JH. Dysfunctional prefrontal regional specialization and compensation in schizophrenia. The American Journal of Psychiatry. 163: 1969-77. PMID 17074949 DOI: 10.1176/appi.ajp.163.11.1969  0.01
2006 Winterer G, Musso F, Beckmann C, Mattay V, Egan MF, Jones DW, Callicott JH, Coppola R, Weinberger DR. Instability of prefrontal signal processing in schizophrenia. The American Journal of Psychiatry. 163: 1960-8. PMID 17074948 DOI: 10.1176/appi.ajp.163.11.1960  0.01
2006 Clarke DK, Cooper D, Egan MA, Hendry RM, Parks CL, Udem SA. Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector. Springer Seminars in Immunopathology. 28: 239-53. PMID 16977404 DOI: 10.1007/s00281-006-0042-3  0.01
2006 Winterer G, Egan MF, Kolachana BS, Goldberg TE, Coppola R, Weinberger DR. Prefrontal electrophysiologic "noise" and catechol-O-methyltransferase genotype in schizophrenia. Biological Psychiatry. 60: 578-84. PMID 16730334 DOI: 10.1016/j.biopsych.2006.03.023  0.01
2006 Talkowski ME, Seltman H, Bassett AS, Brzustowicz LM, Chen X, Chowdari KV, Collier DA, Cordeiro Q, Corvin AP, Deshpande SN, Egan MF, Gill M, Kendler KS, Kirov G, Heston LL, et al. Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biological Psychiatry. 60: 152-62. PMID 16631129 DOI: 10.1016/J.Biopsych.2006.02.015  0.01
2006 Marenco S, Steele SU, Egan MF, Goldberg TE, Straub RE, Sharrief AZ, Weinberger DR. Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex. The American Journal of Psychiatry. 163: 740-2. PMID 16585454 DOI: 10.1176/appi.ajp.163.4.740  0.01
2006 Meyer-Lindenberg A, Buckholtz JW, Kolachana B, R Hariri A, Pezawas L, Blasi G, Wabnitz A, Honea R, Verchinski B, Callicott JH, Egan M, Mattay V, Weinberger DR. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proceedings of the National Academy of Sciences of the United States of America. 103: 6269-74. PMID 16569698 DOI: 10.1073/pnas.0511311103  0.01
2006 Goldberg TE, Straub RE, Callicott JH, Hariri A, Mattay VS, Bigelow L, Coppola R, Egan MF, Weinberger DR. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2022-32. PMID 16554747 DOI: 10.1038/sj.npp.1301049  0.01
2006 Schadeck EB, Sidhu M, Egan MA, Chong SY, Piacente P, Masood A, Garcia-Hand D, Cappello S, Roopchand V, Megati S, Quiroz J, Boyer JD, Felber BK, Pavlakis GN, Weiner DB, et al. A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques. Vaccine. 24: 4677-87. PMID 16288822 DOI: 10.1016/J.Vaccine.2005.10.035  0.01
2006 Egan MA, Megati S, Roopchand V, Garcia-Hand D, Luckay A, Chong SY, Rosati M, Sackitey S, Weiner DB, Felber BK, Pavlakis GN, Israel ZR, Eldridge JH, Sidhu MK. Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice. Vaccine. 24: 4510-23. PMID 16140439 DOI: 10.1016/J.Vaccine.2005.08.024  0.01
2005 Egan MA. Actively immunizing patients with HIV-1: Progress on the development of a therapeutic vaccine. Discovery Medicine. 5: 58-63. PMID 20704925  0.01
2005 Egan MA, Chong SY, Megati S, Montefiori DC, Rose NF, Boyer JD, Sidhu MK, Quiroz J, Rosati M, Schadeck EB, Pavlakis GN, Weiner DB, Rose JK, Israel ZR, Udem SA, et al. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. Aids Research and Human Retroviruses. 21: 629-43. PMID 16060834 DOI: 10.1089/Aid.2005.21.629  0.01
2005 Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR, Verchinski BA, Meyer-Lindenberg A, Balkissoon R, Kolachana B, Goldberg TE, Weinberger DR. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 102: 8627-32. PMID 15939883 DOI: 10.1073/pnas.0500515102  0.01
2005 Blasi G, Mattay VS, Bertolino A, Elvevåg B, Callicott JH, Das S, Kolachana BS, Egan MF, Goldberg TE, Weinberger DR. Effect of catechol-O-methyltransferase val158met genotype on attentional control. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5038-45. PMID 15901785 DOI: 10.1523/JNEUROSCI.0476-05.2005  0.01
2005 Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience. 8: 828-34. PMID 15880108 DOI: 10.1038/Nn1463  0.01
2005 Meyer-Lindenberg AS, Olsen RK, Kohn PD, Brown T, Egan MF, Weinberger DR, Berman KF. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Archives of General Psychiatry. 62: 379-86. PMID 15809405 DOI: 10.1001/Archpsyc.62.4.379  0.01
2005 Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, Weinberger DR. A susceptibility gene for affective disorders and the response of the human amygdala. Archives of General Psychiatry. 62: 146-52. PMID 15699291 DOI: 10.1001/Archpsyc.62.2.146  0.01
2005 Sporn A, Greenstein D, Gogtay N, Sailer F, Hommer DW, Rawlings R, Nicolson R, Egan MF, Lenane M, Gochman P, Weinberger DR, Rapoport JL. Childhood-onset schizophrenia: smooth pursuit eye-tracking dysfunction in family members. Schizophrenia Research. 73: 243-52. PMID 15653267 DOI: 10.1016/J.Schres.2004.07.020  0.01
2004 Egan MA, Chong SY, Rose NF, Megati S, Lopez KJ, Schadeck EB, Johnson JE, Masood A, Piacente P, Druilhet RE, Barras PW, Hasselschwert DL, Reilly P, Mishkin EM, Montefiori DC, et al. Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes. Aids Research and Human Retroviruses. 20: 989-1004. PMID 15585086 DOI: 10.1089/Aid.2004.20.989  0.01
2004 Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10099-102. PMID 15537879 DOI: 10.1523/JNEUROSCI.2680-04.2004  0.01
2004 Weickert TW, Goldberg TE, Mishara A, Apud JA, Kolachana BS, Egan MF, Weinberger DR. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biological Psychiatry. 56: 677-82. PMID 15522252 DOI: 10.1016/j.biopsych.2004.08.012  0.01
2004 Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics. 75: 807-21. PMID 15457404 DOI: 10.1086/425589  0.01
2004 Egan MA. Current prospects for the development of a therapeutic vaccine for the treatment of HIV type 1 infection. Aids Research and Human Retroviruses. 20: 794-806. PMID 15320982 DOI: 10.1089/0889222041725244  0.01
2004 Egan MA, Chong SY, Hagen M, Megati S, Schadeck EB, Piacente P, Ma BJ, Montefiori DC, Haynes BF, Israel ZR, Eldridge JH, Staats HF. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques. Vaccine. 22: 3774-88. PMID 15315859 DOI: 10.1016/j.vaccine.2004.03.011  0.01
2004 Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 101: 12604-9. PMID 15310849 DOI: 10.1073/Pnas.0405077101  0.01
2004 Winterer G, Coppola R, Goldberg TE, Egan MF, Jones DW, Sanchez CE, Weinberger DR. Prefrontal broadband noise, working memory, and genetic risk for schizophrenia. The American Journal of Psychiatry. 161: 490-500. PMID 14992975 DOI: 10.1176/appi.ajp.161.3.490  0.01
2003 Winterer G, Coppola R, Egan MF, Goldberg TE, Weinberger DR. Functional and effective frontotemporal connectivity and genetic risk for schizophrenia. Biological Psychiatry. 54: 1181-92. PMID 14643085 DOI: 10.1016/S0006-3223(03)00532-8  0.01
2003 Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. The American Journal of Psychiatry. 160: 2209-15. PMID 14638592 DOI: 10.1176/appi.ajp.160.12.2209  0.01
2003 Winterer G, Egan MF, Raedler T, Sanchez C, Jones DW, Coppola R, Weinberger DR. P300 and genetic risk for schizophrenia. Archives of General Psychiatry. 60: 1158-67. PMID 14609891 DOI: 10.1001/archpsyc.60.11.1158  0.01
2003 Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS, Goldman D, Weinberger DR. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry. 60: 889-96. PMID 12963670 DOI: 10.1001/Archpsyc.60.9.889  0.01
2003 Apud JA, Egan MF, Wyatt RJ. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis. Schizophrenia Research. 63: 151-60. PMID 12892869 DOI: 10.1016/S0920-9964(02)00338-9  0.01
2003 Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6690-4. PMID 12890761 DOI: 10.1523/Jneurosci.23-17-06690.2003  0.01
2003 Egan MF, Weinberger DR, Lu B. Schizophrenia, III: brain-derived neurotropic factor and genetic risk. The American Journal of Psychiatry. 160: 1242. PMID 12832235 DOI: 10.1176/APPI.AJP.160.7.1242  0.01
2003 Barouch DH, Kunstman J, Glowczwskie J, Kunstman KJ, Egan MA, Peyerl FW, Santra S, Kuroda MJ, Schmitz JE, Beaudry K, Krivulka GR, Lifton MA, Gorgone DA, Wolinsky SM, Letvin NL. Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys. Journal of Virology. 77: 7367-75. PMID 12805435 DOI: 10.1128/JVI.77.13.7367-7375.2003  0.01
2003 Weickert TW, Goldberg TE, Marenco S, Bigelow LB, Egan MF, Weinberger DR. Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1491-500. PMID 12799617 DOI: 10.1038/sj.npp.1300216  0.01
2003 Raedler TJ, Knable MB, Jones DW, Urbina RA, Egan MF, Weinberger DR. Central muscarinic acetylcholine receptor availability in patients treated with clozapine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1531-7. PMID 12799613 DOI: 10.1038/sj.npp.1300210  0.01
2003 Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences of the United States of America. 100: 6186-91. PMID 12716966 DOI: 10.1073/pnas.0931309100  0.01
2003 Callicott JH, Egan MF, Mattay VS, Bertolino A, Bone AD, Verchinksi B, Weinberger DR. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. The American Journal of Psychiatry. 160: 709-19. PMID 12668360 DOI: 10.1176/appi.ajp.160.4.709  0.01
2003 Nicolson R, Brookner FB, Lenane M, Gochman P, Ingraham LJ, Egan MF, Kendler KS, Pickar D, Weinberger DR, Rapoport JL. Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. The American Journal of Psychiatry. 160: 490-5. PMID 12611830 DOI: 10.1176/Appi.Ajp.160.3.490  0.01
2003 Sherry E, Egan M, Warnke PH, Henderson A, Eslick GD. Minimal invasive surgery for hip replacement: a new technique using the NILNAV hip system. Anz Journal of Surgery. 73: 157-61. PMID 12608981  0.01
2003 Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 112: 257-69. PMID 12553913 DOI: 10.1016/S0092-8674(03)00035-7  0.01
2003 Chrapusta SJ, Egan MF, Wyatt RJ, Weinberger DR, Lipska BK. Neonatal ventral hippocampal damage modifies serum corticosterone and dopamine release responses to acute footshock in adult Sprague-Dawley rats. Synapse (New York, N.Y.). 47: 270-7. PMID 12539200 DOI: 10.1002/Syn.10179  0.01
2003 Raedler TJ, Knable MB, Jones DW, Urbina RA, Gorey JG, Lee KS, Egan MF, Coppola R, Weinberger DR. In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. The American Journal of Psychiatry. 160: 118-27. PMID 12505810 DOI: 10.1176/appi.ajp.160.1.118  0.01
2003 Egan MF, Goldberg TE. Intermediate cognitive phenotypes associated with schizophrenia. Methods in Molecular Medicine. 77: 163-97. PMID 12298369 DOI: 10.1385/1-59259-348-8:163  0.01
2002 Weickert TW, Terrazas A, Bigelow LB, Malley JD, Hyde T, Egan MF, Weinberger DR, Goldberg TE. Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input. Learning & Memory (Cold Spring Harbor, N.Y.). 9: 430-42. PMID 12464703 DOI: 10.1101/lm.49102  0.01
2002 Marenco S, Egan MF, Goldberg TE, Knable MB, McClure RK, Winterer G, Weinberger DR. Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series. Schizophrenia Research. 57: 221-6. PMID 12223253 DOI: 10.1016/S0920-9964(01)00311-5  0.01
2002 Sherry E, Egan M, Henderson A, Warnke PH. Minimally invasive techniques for total hip arthroplasty. The Journal of Bone and Joint Surgery. American Volume. 84: 1481; author reply 1. PMID 12177284  0.01
2002 Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR. Serotonin transporter genetic variation and the response of the human amygdala. Science (New York, N.Y.). 297: 400-3. PMID 12130784 DOI: 10.1126/Science.1071829  0.01
2002 Hamid EH, Hyde TM, Egan MF, Wolf SS, Herman MM, Nemeroff CB, Kleinman JE. Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders. Biological Psychiatry. 51: 795-800. PMID 12007453 DOI: 10.1016/S0006-3223(01)01325-7  0.01
2002 Egan M, Goldman D, Weinberger D. The human genome: mutations American Journal of Psychiatry. 159: 12. PMID 11772682 DOI: 10.1176/Appi.Ajp.159.1.12  0.01
2002 Egan MA, Israel ZR. The use of cytokines and chemokines as genetic adjuvants for plasmid DNA vaccines Clinical and Applied Immunology Reviews. 2: 255-287. DOI: 10.1016/S1529-1049(02)00051-X  0.01
2001 Barouch DH, Craiu A, Santra S, Egan MA, Schmitz JE, Kuroda MJ, Fu TM, Nam JH, Wyatt LS, Lifton MA, Krivulka GR, Nickerson CE, Lord CI, Moss B, Lewis MG, et al. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys. Journal of Virology. 75: 2462-7. PMID 11160750 DOI: 10.1128/Jvi.75.5.2462-2467.2001  0.01
2001 Buck CB, Shen X, Egan MA, Pierson TC, Walker CM, Siliciano RF. The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. Journal of Virology. 75: 181-91. PMID 11119587 DOI: 10.1128/Jvi.75.1.181-191.2001  0.01
2000 Egan MA, Charini WA, Kuroda MJ, Schmitz JE, Racz P, Tenner-Racz K, Manson K, Wyand M, Lifton MA, Nickerson CE, Fu T, Shiver JW, Letvin NL. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection. Journal of Virology. 74: 7485-95. PMID 10906202 DOI: 10.1128/JVI.74.16.7485-7495.2000  0.01
1999 Egan MA, Kuroda MJ, Voss G, Schmitz JE, Charini WA, Lord CI, Forman MA, Letvin NL. Use of Major Histocompatibility Complex Class I/Peptide/β2M Tetramers To Quantitate CD8+ Cytotoxic T Lymphocytes Specific for Dominant and Nondominant Viral Epitopes in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys Journal of Virology. 73: 5466-5472. DOI: 10.1128/jvi.73.7.5466-5472.1999  0.01
1997 Egan MA, Carruth LM, Rowell JF, Yu X, Siliciano RF. The ins and outs of HIV endocytosis. Trends in Cell Biology. 7: 49. PMID 17708904 DOI: 10.1016/S0962-8924(97)82670-0  0.01
1996 Bollinger RC, Egan MA, Chun TW, Mathieson B, Siliciano RF. Cellular immune responses to HIV-1 in progressive and non-progressive infections. Aids (London, England). 10: S85-96. PMID 8883615 DOI: 10.1097/00002030-199601001-00013  0.01
1996 Egan MA, Carruth LM, Rowell JF, Yu X, Siliciano RF. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. Journal of Virology. 70: 6547-56. PMID 8794289 DOI: 10.1128/Jvi.70.10.6547-6556.1996  0.01
1995 Egan MA, Pavlat WA, Tartaglia J, Paoletti E, Weinhold KJ, Clements ML, Siliciano RF. Induction of human immunodeficiency virus type 1 (hiv-1)-specific cytolytic t lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (alvac) carrying the hiv-1mn env gene Journal of Infectious Diseases. 171: 1623-1627. PMID 7769304 DOI: 10.1093/Infdis/171.6.1623  0.01
1994 Lubaki MN, Egan MA, Siliciano RF, Weinhold KJ, Bollinger RC. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes Aids Research and Human Retroviruses. 10: 1427-1431. PMID 7888197 DOI: 10.1089/Aid.1994.10.1427  0.01
1992 Ei-Mallakh RS, Egan M, Jed Wyatt R. Creatine Kinase and Enolase: Intracellular Enzymes Serving as Markers of Central Nervous System Damage in Neuropsychiatric Disorders. Psychiatry. 55: 392-402. PMID 27707363 DOI: 10.1080/00332747.1992.11024612  0.01
Hide low-probability matches.